Methodologies for extracting functional pharmacogenomic experiments from international repository.
Yi‐An Lin, Annie Chiang, Ray Lin et al. · PubMed · 2007
Pharmacogenomic studies are studies designed to elucidate the relationships between drugs and genes on the genomic scale. Given the rapidly increasing amount of microarray data in international repositories, and the implicit drug information contained in PubMed, MeSH and UMLS, we propose automatic methods for identifying drug-related microarray experiments from NCBI GEO by the semantic connections between these data resources. In our study, we find that 51.5% of microarray experiments are associated with at least one PubMed identifier, 22.1% of these contain a MeSH term that relates to the UMLS Pharmacologic Substances semantic sub-tree. Our work shows an abundance of publicly available gene expression data available to enable the discovery of novel drug indications, drug classifications and other pharmacogenomic studies.
Cited by 8 works.
Authors
References
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
- Creation and implications of a phenome-genome network
- NCBI GEO standards and services for microarray data
- The Stanford Microarray Database: implementation of new analysis tools and open source release of software
- Finding disease-related genomic experiments within an international repository: first steps in translational bioinformatics.